Tim Funnell

Partner • Monograph Capital

Tim trained as a Pharmacologist with Undergraduate degree from University of Cambridge and DPhil from the University of Oxford before joining the Boston Consulting Group’s London office. Since then Tim has been a biotech investor and company-builder at Syncona, Third Rock Ventures, and Oxford Sciences, gaining experience across therapeutic modalities and geographies. Tim leads Monograph’s investments in Aviado and Ascend.  

Also speaking

Joel Eichmann

Co-Founder • Green Elephant Biotech

Jens Hasskarl

Chief Medical Officer • Tigen Pharma

Anthony Davies

Founder & CEO • Dark Horse Consulting

Event Info


Spotlight Roundtables

Take a look at the sample attendee list for Advanced Therapies Europe here.

Pub & Pints RSVP

Let us know you’re planning on attending.